PaulRiskaMD

Infectious Disease • Bronx, NY

HIV/AIDS Medicine

Associate Professor of Clinical Medicine, Infectious Diseases, Albert Einstein College of Medicine

Join to view full profile

Dr. Riska is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Riska's full profile

Already have an account?

Office
3444 Kossuth Ave
Bronx, NY 10467
Phone+1 718-920-8542

Fax+1 718-405-0610
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1992 - 1998
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1992
Duke University School of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1990 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Respiratory Virus Hospitalization Study (FLU 003 Plus) Start of enrollment: 2009 Aug 01
Recruiting
Roles: Principal Investigator, Contact
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Start of enrollment: 2011 Feb 01
Completed
Phase 2
Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics. Start of enrollment: 2019 Aug 30
Terminated
Phase 4

Publications & Presentations

PubMed

7 citations
Anorectal Testing for Mpox Virus Infection in Men Who Have Sex With Men With and Without Proctitis.
Eric A Meyerowitz, Inessa Gendlina, Vimi J Desai, Robert Grossberg, Singh R Nair, Beendu Pujar, Paul F Riska, Heather B Root, Justin Toro, Julian A Torres, Liise-Anne ...> ;Clinical Infectious Diseases. 2023 Mar 4
2 citations
Unexpected case of cryptococcal meningoencephalitis in a patient with long-standing well-controlled HIV infection.
Hyun Ah Yoon, Paul F. Riska, Ruchika Jain, Cariane Morales, Liise Anne Pirofski> ;Medical Mycology Case Reports. 2021 Jan 26
92 citations
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patie...
, , , , , , , , , , , , , , , , , , , , , > ;Clinical Infectious Diseases. 2020 Apr 10
86 citations
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Richard T. Davey, Eduardo Fernández-Cruz, Norman Markowitz, Sarah Pett, Abdel Babiker, Deborah Wentworth, Surender Khurana, Nicole Engen, Fred M. Gordin, Mamta K. Jain...> ;The Lancet. Respiratory Medicine. 2019 Sep 30
40 citations
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial
Thomas L. Holland, Issam I Raad, Helen W. Boucher, Deverick J. Anderson, Sara E. Cosgrove, P. Suzanne Aycock, John W. Baddley, Anne Marie Chaftari, Shein-Chung Chow, V...> ;JAMA. 2018 Sep 25
13 citations
Two for the price of one: emerging carbapenemases in a returning traveller to New York City.
Jaimie Mittal, Wendy Szymczak, Yi Guo, Michael H. Levi, Liang Chen, Barry N. Kreiswirth, Paul F. Riska, Priya Nori> ;BMJ Case Reports. 2018 Jul 18
15 citations
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicat...
Teresa L. Kauf, Peggy McKinnon, G. Ralph Corey, John Bedolla, Paul F. Riska, Matthew Sims, Bruce Friedman, James D. Hoehns, Renee-Claude Mercier, Julia Garcia-Diaz, Su...> ;BMC Infectious Diseases. 2015 Nov 7
4 citations
Toxocariasis presenting as eosinophilic ascites in a post-partum female
Malini Guha, Sunit Jariwala, Nana Jinjolova, Nicole Mazer, Elizabeth Revere, Paul F. Riska, Elina Jerschow> ;Journal of Parasitic Diseases. 2015 Jun 1
Lessons Learned from Implementing Clostridium difficile-Focused Antibiotic Stewardship Interventions.
Ostrowsky, B.,Ruiz, R.,Brown, S.,Chung, P.,Koppelman, E.,van Deusen Lukas, C.,Guo, Y.,Jalon, H.,Sumer, Z.,Araujo, C.,Sirtalan, I.,Brown, C.,Riska, P.,Currie, B.> ;Infect Control Hosp Epidemiol. 2014 Sep 16
46 citations
Loop-Mediated Isothermal Amplification Compared to Real-Time PCR and Enzyme Immunoassay for Toxigenic Clostridium difficile Detection
Bobby L. Boyanton, Preethi Sural, Caroline R. Loomis, Christine Pesta, Laura Gonzalez-Krellwitz, Barbara Robinson-Dunn, Paul F. Riska> ;Journal of Clinical Microbiology. 2012 Mar 1
103 citations
Comparison of BD GeneOhm Cdiff Real-Time PCR Assay with a Two-Step Algorithm and a Toxin A/B Enzyme-Linked Immunosorbent Assay for Diagnosis of Toxigenic Clostridium d...
Elizabeth Kvach, David Ferguson, Paul F. Riska, Marie L. Landry> ;Journal of Clinical Microbiology. 2010 Jan 1
3 citations
In vitro models of acute and long-term continuous infection of human respiratory epithelial cells with Chlamydophila pneumoniae have opposing effects on host cell apop...
Stephan Kohlhoff, Andrei Kutlin, Paul F. Riska, Patricia M. Roblin, Christopher Roman, Margaret R. Hammerschlag> ;Microbial Pathogenesis. 2008 Jan 1
36 citations
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.
Andrei Kutlin, Stephan Kohlhoff, Patricia M. Roblin, Margaret R. Hammerschlag, Paul F. Riska> ;Antimicrobial Agents and Chemotherapy. 2005 Mar 1
8 citations
Genetic and Culture-Based Approaches for Detecting Macrolide Resistance in Chlamydia pneumoniae
Paul F. Riska, Andrei Kutlin, Patrick Ajiboye, Arnold Cua, Patricia M. Roblin, Margaret R. Hammerschlag> ;Antimicrobial Agents and Chemotherapy. 2004 Sep 1
35 citations
Photographic and Luminometric Detection of Luciferase Reporter Phages for Drug Susceptibility Testing of Clinical Mycobacterium tuberculosis Isolates
Manzour Hernando Hazbón, Nora Guarín, Beatriz E. Ferro, Ana Rodríguez, Luz Angela Labrada, Rafael Tovar, Paul F. Riska, William R. Jacobs> ;Journal of Clinical Microbiology. 2003 Oct 1
42 citations
Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages
Niaz Banaiee, Miriam Bobadilla-del-Valle, Paul F. Riska, Svetoslav Bardarov, Peter M. Small, Alfredo Ponce-de-León, William R. Jacobs, Graham F. Hatfull, José Sifuente...> ;Journal of Medical Microbiology. 2003 Jul 1
51 citations
Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tub...
Svetoslav Bardarov, Horng Dou, Katherine Eisenach, Niaz Banaiee, S.u Ya, John Chan, William R. Jacobs, Paul F. Riska> ;Diagnostic Microbiology and Infectious Disease. 2003 Jan 1
9 citations
Latent tuberculosis: models, mechanisms, and novel prospects for eradication.
Paul F. Riska, Stephen Carleton> ;Seminars in Pediatric Infectious Diseases. 2002 Oct 1
14 citations
Effectiveness of directly observed therapy (DOT) for tuberculosis: A review of multinational experience reported in 1990-2000
A. Ross Hill, Vivek M. Manikal, Paul F. Riska> ;Medicine. 2002 May 1
62 citations
Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.
Niaz Banaiee, Miriam Bobadilla-del-Valle, Svetoslav Bardarov, Paul F. Riska, Peter M. Small, Alfredo Ponce-de-León, William R. Jacobs, Graham F. Hatfull, J. Sifuentes-...> ;Journal of Clinical Microbiology. 2001 Nov 1
Molecular determinants of drug resistance in tuberculosis.
Riska, P. F.,Jacobs, W. R.,Alland, D.> ;Int. J. Tuberc. Lung Dis.. 2000 Feb 01
67 citations
Molecular determinants of drug resistance in tuberculosis.
Paul F. Riska, William R. Jacobs, David Alland> ;The International Journal of Tuberculosis and Lung Disease. 2000 Feb 1
56 citations
Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.
Paul F. Riska, Ya Su, Svetoslav Bardarov, Lawrence Freundlich, Gary J. Sarkis, Graham F. Hatfull, Christian Carriere, Vanaja Kumar, John Chan, William R. Jacobs> ;Journal of Clinical Microbiology. 1999 Apr 1
25 citations
The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria.
Paul F. Riska, William R. Jacobs> ;Methods in Molecular Biology. 1998 Jan 1
42 citations
Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone.
Paul F. Riska, William R. Jacobs, Barry R. Bloom, John C. McKitrick, John Chan> ;Journal of Clinical Microbiology. 1997 Dec 1
Join now to see all

Journal Articles

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia
Issam Raad, Mark E Rupp, Thomas L Holland, Helen W Boucher, G Ralph Corey, Paul Riska, Deverick J Anderson, Matthew Sims, Dannah Wray, Sara E Cosgrove, Manuela Carugat..., JAMA

Hospital Affiliations

Montefiore Medical CenterBronx, New York